1-8 of 8
Eleonora Russo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LONG-TERM Outcome of a Fondazione Italiana Linfomi Study Comparing Short Rituximab Maintenance Vs Observation after Brief First-LINE R-FND Chemoimmunotherapy Followed By Rituximab Consolidation in Elderly Patients with Advanced Follicular Lymphoma (FL)

Carola Boccomini, MD, Marco Ladetto, MD, Francesca Dutto, Simone Ferrero, MD, Luca Baldini, MD, Chiara Bottelli, MD, Claudia Castellino, MD, Annalisa Chiarenza, MD, Annarita Conconi, MD, Federico De Angelis, MD, Andrea Evangelista, Stefan Hohaus, MD, Francesco Merli, MD, Benedetta Puccini, MD, Chiara Rusconi, MD, Eleonora Russo, MD, Stefano Sacchi, MD, Stefano Volpetti, MD, Giuseppe Rossi, MD, Umberto Vitolo, MD
Journal: Blood
Blood (2015) 126 (23): 3985.
https://doi.org/10.1182/blood.V126.23.3985.3985
Published: 2015
Journal Articles

Peripheral T-Cell Lymphomas (PTCL) Treated With Or Without Upfront Autologous Stem Cell Transplantation: Results Of a Retrospective Single Center Analysis

Alice Di Rocco, MD, Angelo Fama, MD, Eleonora Russo, MD, Giovanna Meloni, MD, Paolo Paesano, MD, Laura Cesini, MD, Michela Ansuinelli, MD, Saveria Capria, MD, Maurizio Martelli, MD, Robin Foá, MD
Journal: Blood
Blood (2013) 122 (21): 5548.
https://doi.org/10.1182/blood.V122.21.5548.5548
Published: 2013
Journal Articles

Impact Of Bone Marrow Involvement On Outcome Of Young Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL) Treated In The Phase III Randomized Trial (DLCL04) With Rituximab Dose-Dense Chemotherapy Followed By Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Or Standard Rituximab Dose Dense Chemotherapy: A Study of The Fondazione Italiana Linfomi (FIL)

Umberto Vitolo, MD, Annalisa Chiappella, Ercole Brusamolino, Emanuele Angelucci, Giuseppe Rossi, Angelo Michele Carella, Andrea Evangelista, Caterina Stelitano, Monica Balzarotti, Francesco Merli, Gianluca Gaidano, Manuel Gotti, Vincenzo Pavone, Luigi Rigacci, Francesco Zaja, Chiara Rusconi, MD, Amalia De Renzo, Graziella Pinotti, Michele Pizzuti, Michele Spina, Maria Cantonetti, Giorgina Specchia, Patrizia Pregno, MD, Eleonora Russo, MD, Alessandra Tucci, Maria Giuseppina Cabras, Stefano A Pileri, Alessandro Levis, Maurizio Martelli, MD
Journal: Blood
Blood (2013) 122 (21): 4340.
https://doi.org/10.1182/blood.V122.21.4340.4340
Published: 2013
Journal Articles

Efficacy and Safety Of Melphalan and Prednisone In Combination With Thalidomide, Bortezomib Or Lenalidomide In Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients: A Single Center Experience

Fabiana Gentilini, MD, Vincenzo Federico, MD, Eleonora Russo, MD, Paola Finsinger, MD, Roberto Ricci, Patrizia Del Bianco, Francesca Prestanicola, Moira Cappelloni, Maria Letizia Vallone, Robin Foa, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2013) 122 (21): 5375.
https://doi.org/10.1182/blood.V122.21.5375.5375
Published: 2013
Journal Articles

Rituximab Dose-Dense Chemotherapy Followed by Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Significantly Reduces the Risk of Progression Compared to Standard Rituximab Dose-Dense Chemotherapy As First Line Treatment in Young Patients with High-Risk (aa-IPI 2–3) Diffuse Large B-Cell Lymphoma (DLBCL): Final Results of Phase III Randomized Trial DLCL04 of the Fondazione Italiana Linfomi (FIL)

Umberto Vitolo, Annalisa Chiappella, Ercole Brusamolino, Emanuele Angelucci, MD, Giuseppe Rossi, Angelo Michele Carella, Andrea Evangelista, Caterina Stelitano, Monica Balzarotti, Francesco Merli, Gianluca Gaidano, MD, PhD, Vincenzo Pavone, Luigi Rigacci, MD, Francesco Zaja, MD, Nicola Cascavilla, Alfonso Maria D'Arco, Chiara Rusconi, Amalia De Renzo, Graziella Pinotti, MD, Michele Spina, Patrizia Pregno, Eleonora Russo, MD, PhD, Manuel Gotti, Alessandra Tucci, Maria Giuseppina Cabras, MD, Stefano A. Pileri, MD, Alessandro Levis, MD, Maurizio Martelli, MD
Journal: Blood
Blood (2012) 120 (21): 688.
https://doi.org/10.1182/blood.V120.21.688.688
Published: 2012
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients

Antonio Palumbo, MD, Sara Bringhen, Oreste Villani, Agostina Siniscalchi, MD, Eleonora Russo, MD, PhD, Giuseppina Uccello, MD, Chiara Cerrato, MD, Milena Gilestro, Davide Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 730.
https://doi.org/10.1182/blood.V120.21.730.730
Published: 2012
Journal Articles

Increased Risk of Thrombotic Events in Patients with Acute Promyelocytic Leukemia (APL) Receiving ATRA Treatment: Does It Correlate with CD2 and FLT3 Expression?.

Massimo Breccia, MD, Roberto Latagliata, MD, Ida Carmosino, MD, Eleonora Russo, MD, Mariella D’Andrea, MD, Erica Finolezzi, MD, Nicol Iorio, MD, Cinzia Fazio, MD, Giuseppe Avvisati, PhD, Maria Concetta Petti, PhD, Francesco Lo-Coco, PhD, Franco Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 887.
https://doi.org/10.1182/blood.V106.11.887.887
Published: 2005
Journal Articles

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Roberto Latagliata, MD, Massimo Breccia, MD, Ida Carmosino, MD, Chiara Sarlo, MD, Rosa De Cuia, MD, Marco Mancini, MD, Francesca Biondo, MD, Eleonora Russo, MD, Annalisa De Vellis, MD, Daniela Diverio, MD, Franco Mandelli, PhD, Giuliana Alimena, PhD
Journal: Blood
Blood (2004) 104 (11): 4693.
https://doi.org/10.1182/blood.V104.11.4693.4693
Published: 2004